• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Study of clinical efficiency of essential phospholipids and silymarin combination in nonalcoholic and alcoholic steatohepatitis].

作者信息

Iakimchuk G N, Gendrikson L N

出版信息

Eksp Klin Gastroenterol. 2011(7):64-9.

PMID:22364002
Abstract

The issues of steatohepatitis treatment in the pathogenesis of which a major role plays lipid accumulation in hepatocyte and increased processes of free radical oxidation of lipids. Developed a method of treatment of patients with alcoholic and nonalcoholic steatohepatitis with the inclusion of a combination of essential phospholipids (EPL) and silymarin (SM). A comparative assessment of results of treatment with the inclusion of a combination of EPL and SM, Essentiale and Carsil in 60 patients with alcoholic and nonalcoholic steatohepatitis. Revealed the preferential efficiency of combination EPL and SM in these patients in regard of shortening the time clinical manifestations of disease, reducing transaminase activity, normalization of the cholestasis and cholesterol. Given practical recommendations of treatment patients with alcoholic and nonalcoholic steatohepatitis with the inclusion of a combination of EPL and CM.

摘要

相似文献

1
[Study of clinical efficiency of essential phospholipids and silymarin combination in nonalcoholic and alcoholic steatohepatitis].
Eksp Klin Gastroenterol. 2011(7):64-9.
2
[Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C].[酒精性肝病和慢性丙型肝炎中的氧化应激与抗氧化防御]
Orv Hetil. 2000 Jul 23;141(30):1655-9.
3
Serum ubiquitin levels in patients with nonalcoholic steatohepatitis.非酒精性脂肪性肝炎患者的血清泛素水平
Hepatogastroenterology. 2003 May-Jun;50(51):738-41.
4
[Use of Legalon in non-alcoholic fatty liver disease].[利加隆在非酒精性脂肪性肝病中的应用]
Eksp Klin Gastroenterol. 2010(5):69-75.
5
Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis.非酒精性脂肪性肝炎与酒精性肝炎的比较。
Am J Gastroenterol. 1987 Jul;82(7):650-4.
6
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial.水飞蓟宾联合磷脂酰胆碱和维生素 E 治疗非酒精性脂肪性肝病的随机对照研究。
Free Radic Biol Med. 2012 May 1;52(9):1658-65. doi: 10.1016/j.freeradbiomed.2012.02.008. Epub 2012 Feb 15.
7
Fibrosis in alcoholic and nonalcoholic steatohepatitis.酒精性和非酒精性脂肪性肝炎的纤维化。
Best Pract Res Clin Gastroenterol. 2011 Apr;25(2):231-44. doi: 10.1016/j.bpg.2011.02.010.
8
Plasma lipid parameters in patients with alcoholic fatty liver after treatment with essential phospholipids.用必需磷脂治疗后酒精性脂肪肝患者的血浆脂质参数
Bratisl Lek Listy. 2003;104(7-8):227-31.
9
The role of lipid metabolism in the pathogenesis of alcoholic and nonalcoholic hepatic steatosis.脂质代谢在酒精性和非酒精性肝脂肪变性发病机制中的作用。
Semin Liver Dis. 2010 Nov;30(4):378-90. doi: 10.1055/s-0030-1267538. Epub 2010 Oct 19.
10
A silybin-phospholipid complex prevents mitochondrial dysfunction in a rodent model of nonalcoholic steatohepatitis.水飞蓟宾磷脂复合物可预防非酒精性脂肪性肝炎啮齿动物模型中的线粒体功能障碍。
J Pharmacol Exp Ther. 2010 Mar;332(3):922-32. doi: 10.1124/jpet.109.161612. Epub 2009 Dec 11.

引用本文的文献

1
Role of silymarin as antioxidant in clinical management of chronic liver diseases: a narrative review.水飞蓟素作为抗氧化剂在慢性肝病临床治疗中的作用:叙述性综述。
Ann Med. 2022 Dec;54(1):1548-1560. doi: 10.1080/07853890.2022.2069854.